Cargando…
Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease
There is a pressing need for more precise biomarkers of chronic kidney disease (CKD). Plasma samples from 820 subjects [231 with CKD, 325 with end-stage kidney disease (ESKD) and 264 controls] were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS) to determine a metabolic pr...
Autores principales: | Gervasini, Guillermo, Verde, Zoraida, González, Luz M., Chicharro, Celia, González-Rodríguez, Laura, Fernández-Araque, Ana, Mota-Zamorano, Sonia, Cancho, Bárbara, Pérez-Hernández, Alberto, García-López, Virginio, Bandrés, Fernando, Robles, Nicolás R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604890/ https://www.ncbi.nlm.nih.gov/pubmed/37893147 http://dx.doi.org/10.3390/biomedicines11102775 |
Ejemplares similares
-
A Custom Target Next-Generation Sequencing 70-Gene Panel and Replication Study to Identify Genetic Markers of Diabetic Kidney Disease
por: Mota-Zamorano, Sonia, et al.
Publicado: (2021) -
Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy
por: Mota-Zamorano, Sonia, et al.
Publicado: (2021) -
Plasma and urinary concentrations of arachidonic acid-derived eicosanoids are associated with diabetic kidney disease
por: Mota-Zamorano, Sonia, et al.
Publicado: (2021) -
Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients
por: González, Luz María, et al.
Publicado: (2021) -
Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients
por: González, Luz M., et al.
Publicado: (2023)